Stock Events

Stock Events

Enveric Biosciences 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17AugExpected
Q4 2025
Next
-48.47
-32.07
-15.66
0.74
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-10.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SLZB.STU. It's not an investment recommendation.
Apple
14
AAPL
Tesla
14
TSLA
Palantir Technologies
12
PLTR
Microsoft
11
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap179.35M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Enveric's target indications.
Aurora Cannabis
ACB
Mkt Cap167.86M
Aurora Cannabis is a major player in the cannabis industry, potentially competing in the medical cannabis space where Enveric operates.
Tilray Brands
TLRY
Mkt Cap545.68M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially overlapping with Enveric's market in cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap435.5M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing in the broader market for cannabinoid-based products.

About

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Show more...
CEO
Dr. Joseph Edward Tucker Ph.D.
Employees
7
Country
United States
ISIN
US29405E1091

Listings

STU
DE
SLZ0.STU
STU
DE
SLZB.STU
MU
DE
SLZ0.MU
XNAS
US
ENVB

0 Comments

Share your thoughts

FAQ

What is Enveric Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Enveric Biosciences stocks are traded under the ticker SLZB.STU.
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on August 17, 2026.
What were Enveric Biosciences earnings last quarter?▼
SLZB.STU earnings for the last quarter are 0.74 EUR per share, whereas the estimation was -48.47 EUR resulting in a +101.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Enveric Biosciences revenue for the last year?▼
Enveric Biosciences revenue for the last year amounts to 0 EUR.
What is Enveric Biosciences net income for the last year?▼
SLZB.STU net income for the last year is -10.49M EUR.
How many employees does Enveric Biosciences have?▼
As of July 18, 2026, the company has 7 employees.
In which sector is Enveric Biosciences located?▼
Enveric Biosciences operates in the Health & Wellness sector.
When did Enveric Biosciences complete a stock split?▼
Enveric Biosciences has not had any recent stock splits.
Where is Enveric Biosciences headquartered?▼
Enveric Biosciences is headquartered in Naples, United States.